Shortfall
Eligible Shareholders who take up their Entitlements in full may also apply for Additional New Shares in excess of their Entitlements, at the Offer Price. The availability of Additional New Shares will be limited to the Entitlements attributable to Eligible Shareholders that do not take up their Entitlements. In the event it is necessary to scale-back applications for Additional New Shares (where there are more applications for Additional New Shares than there is Shortfall) then the scale back will be on a pro-rata basis based on your Entitlement. To the extent that any Shortfall Shares remain at the Closing Date,the Board also reserves the right to place any Shortfall Shares at their discretion within three months after the Closing Date.
For the purpose of this Offer Booklet, Shortfall Shares means New Shares available under the Entitlement Offer that are not subscribed for by Eligible Shareholders by the Closing Date
================================
So this clearly means eligible shareholderss are NOT restricted to the 1 for 9.5 offer, and to me seems to imply that a pro-rata scale back will only apply if an oversubscription occurs. So if you want more than your 1 for 9.5 just apply $xxxx's for what you want. Maybe it'll be scaled back maybe not but there does not seem to be an upper limit like $15k or so, as most SPP.
And -
the Board also reserves the right to place any Shortfall Shares at their discretion within three months after the Closing Date.
.. answers your query
Cheers
- Forums
- ASX - By Stock
- Ann: WBT Placement & Entitlement Offer
ShortfallEligible Shareholders who take up their Entitlements in...
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WBT (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.97 |
Change
0.010(0.34%) |
Mkt cap ! $560.1M |
Open | High | Low | Value | Volume |
$2.97 | $3.01 | $2.89 | $1.472M | 500.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25627 | $2.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.97 | 8118 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25627 | 2.930 |
2 | 2659 | 2.920 |
5 | 11033 | 2.910 |
3 | 10249 | 2.900 |
2 | 3532 | 2.890 |
Price($) | Vol. | No. |
---|---|---|
2.970 | 8118 | 1 |
2.980 | 2200 | 1 |
2.990 | 23000 | 2 |
3.000 | 10880 | 3 |
3.010 | 1603 | 2 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$2.95 |
  |
Change
0.010 ( 0.62 %) |
|||
Open | High | Low | Volume | ||
$2.98 | $3.00 | $2.89 | 85058 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
WBT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online